文献速递免疫规划

阿根廷儿童单剂甲型肝炎疫苗接种后12年体液与细胞免疫记忆应答

Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children.
PubMed 文献 · Vaccine · 2021-11-24

本研究对阿根廷81名单剂甲型肝炎疫苗接种儿童(平均随访12年)评估长期免疫记忆:54例抗体水平未达保护者中48/52(92%)在加强接种后达保护水平,27例保护水平者中25/27(93%)抗体仍>10 mUI/mL;47例中HAV特异性记忆CD4+ T细胞检出25/47(53.2%),CD8+ T细胞检出16/47(34.04%),记忆T细胞存在与抗体水平无关。

要点

  • 单剂甲肝疫苗后12年,92%(48/52)抗体未保护者加强后达保护水平
  • 原保护水平者中93%(25/27)抗体仍>10 mUI/mL,7%(2/27)失去保护
  • HAV特异性记忆CD4+ T细胞检出53.2%(25/47),CD8+ T细胞34.04%(16/47)

核心结论

  • 单剂甲肝疫苗后长期免疫记忆存在,包括抗体持久或记忆T细胞应答,提示抗体衰减者仍可能受保护,支持单剂策略。

研究设计与样本

  • 从2015年一项研究中选取81名单剂甲肝疫苗接种者,包括54例抗体未保护水平(UAL)和27例保护抗体水平(PAL)者,平均随访12年。

主要发现

  • UAL组完成随访者中48/52(92%)在加强接种后达保护水平。
  • PAL组中2/27(7%)抗体失去保护,25/27(93%)抗体仍>10 mUI/mL。
  • 47例中HAV特异性记忆CD4+ T细胞检出25/47(53.2%),CD8+ T细胞检出16/47(34.04%)。
  • PAL组记忆CD4+和CD8+ T细胞应答分别检出11/21(52.4%)和9/21(42.9%),UAL组分别检出14/26(53.8%)和7/26(26.9%)。
  • 记忆T细胞存在与抗HAV抗体水平或有无无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infants' universal hepatitis A virus (HAV) single-dose vaccination has been highly effective for controlling HAV infection in Argentina, and in other Latin-American countries that adopted that strategy. Although antibodies wane over time, this has not been associated with HAV outbreaks or breakthrough infections, suggesting a relevant role for memory immunity. This study assessed long term humoral and cellular immune memory response after an average of 12 years follow-up of HAV single-dose vaccination. We selected 81 HAV-single dose vaccinated individuals from a 2015 study, including 54 with unprotective (UAL) and 27 with protective antibody levels (PAL) against HAV. Humoral memory response was assessed by measuring anti-HAV antibody titers at admission in both groups, and 30 days after a booster dose in the UAL group. Flow cytometry analysis of peripheral blood mononuclear cell samples stimulated with HAV antigen was performed in 47/81 individuals (21 with PAL, 26 with UAL) to identify activated CD4 + memory T cells or CD8 + memory T cells. The results showed that 48/52 (92%) individuals from UAL group who completed follow up reached protective levels after booster dose. In the PAL group, anti-HAV Abs waned in 2/27 (7%) individuals lacking seroprotection, while in 25/27 (93%) Abs remained >10 mUI/mL. HAV-specific memory CD4 + T cells were detected in 25/47 (53.2%) subjects while HAV-specific memory CD8 + T cells were observed in 16/47 (34.04%) individuals. HAV-specific memory CD4+ and CD8+ T cell responses were detected in 11/21 (52.4%) and in 9/21 (42.9%) subjects with PAL and in 14/26 (53.8%) and in 7/26 (26.9%) individuals with UAL, showing that the presence of memory T-cells was independent of the level or presence of anti-HAV antibodies. Long-term immunity demonstrated in the present work, including or not antibody persistence, suggests that individuals with waned Ab titers may still be protected and supports the single-dose HAV strategy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Urueña A, Badano MN, Baré P, et al. Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children. Vaccine. 2021. PMID: 34838323. doi:10.1016/j.vaccine.2021.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。